Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Therapeutic class review, Neurological - multiple sclerosis dalfampridine (Ampyra(TM))
Daclizumab reduces CD25 levels on T cells through monocyte-mediated trogocytosis.
The Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis.
Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimod.
Cytokine switch and bystander suppression of autoimmune responses to multiple antigens in experimental autoimmune encephalomyelitis by a single recombinant T-cell receptor ligand.
Quantitative assays for anti-aquaporin-4 antibody with subclass analysis in neuromyelitis optica.
Oral Laquinimod for Multiple Sclerosis Granted Fast Track Status by FDA
Imaging robust microglial activation after lipopolysaccharide administration in humans with PET.
Sphingosine and FTY720 are potent inhibitors of the transient receptor potential melastatin 7 (TRPM7) channels.
Differential roles of microglia and monocytes in the inflamed central nervous system.
Integrated analysis of daclizumab HYP pharmacokinetics from three phase 1 studies
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine.
A genome-wide association study of brain lesion distribution in multiple sclerosis.
Treatment of primary Sjögren syndrome with rituximab: a randomized trial.
Genmab Announces Ofatumumab Development Plans in RRMS and NMO
Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis
Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey.
The Antiaging Protein Klotho Enhances Oligodendrocyte Maturation and Myelination of the CNS.
The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group.
Healthcare resource use and relapses with fingolimod versus natalizumab for treating multiple sclerosis: a retrospective US claims database analysis.
Amiloride: a molecular probe of sodium transport in tissues and cells.
Signal Transduction in the Blood-Brain Barriers
Immunology 2014
Volumetric comparisons of supratentorial white matter hyperintensities on FLAIR MRI in patients with migraine and multiple sclerosis.
Sanofi MS drug nears green light after pass-the-parcel marathon

Pages